SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-17-001061
Filing Date
2017-05-15
Accepted
2017-05-15 16:46:04
Documents
7
Period of Report
2017-05-15

Document Format Files

Seq Description Document Type Size
1 6-K v466838_6k.htm 6-K 18634
2 EXHIBIT 99.1 v466838_ex99-1.htm EX-99.1 135545
3 EXHIBIT 99.2 v466838_ex99-2.htm EX-99.2 271652
4 EXHIBIT 99.3 v466838_ex99-3.htm EX-99.3 127642
5 EXHIBIT 99.4 v466838_ex99-4.htm EX-99.4 10084
6 EXHIBIT 99.5 v466838_ex99-5.htm EX-99.5 10088
7 GRAPHIC image_001.jpg GRAPHIC 11472
  Complete submission text file 0001279569-17-001061.txt   590704
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 17845061
SIC: 2834 Pharmaceutical Preparations